In the immuno-oncology field, scientists discover, test, and validate novel immunotherapeutic agents that leverage the human immune system to fight cancer, such as checkpoint inhibitors, vaccine-based ...

This article is based on a poster originally authored by Yongyang Huang, Ning Guo, Mackenzie Pierce, Leo Chan, Bo Lin and Yi Yang, which was presented at ELRIG Drug Discovery 2024 in affiliation with ...

This article and associated images are based on a poster originally authored by Zhong Yu, Parker Ellingson, Denise Sullivan, Ben Streeter, Austin Passaro, Stacie Chvatal and Daniel Millard and ...

Tom Congdon (left) is the CEO and Co-Founder of CryoLogyx (Coventry, UK), a University of Warwick (UK) spinout that develops technology for cryopreservation of cell-based assays and novel ...

Partillion Bioscience provides Nanovials, engineered microparticles that serve as suspendable reaction compartments for individual cells. Nanovials come in 35 µm or 50 µm diameters, and different ...

Bioassay variability can pose significant challenges due to laboratory conditions, instrumentation, analytical software, cell ...

Artificial intelligence-supported cell imaging could help laboratories to set defensible quality thresholds for living ...

CellVoyant, a U.K.-based startup, has launched an AI platform that allows scientists to predict the future health and ...

Cellular immunogenicity and immunotoxicity assays help scientists design, validate, and translate therapeutic research into treatments that weaponize the immune response against cancer.